Format

Send to

Choose Destination
Vet Clin North Am Small Anim Pract. 2017 Sep;47(5):1065-1082. doi: 10.1016/j.cvsm.2017.05.001. Epub 2017 Jun 27.

Feline Cardiogenic Arterial Thromboembolism: Prevention and Therapy.

Author information

1
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, Lynn Hall, 625 Harrison Street, West Lafayette, IN 47907-2026, USA. Electronic address: hogandf@purdue.edu.

Abstract

Feline cardiogenic arterial thromboembolism (CATE) is a devastating disease whereby 33% of cats survive their initial event, although approximately 50% of mortality is from euthanasia. Short-term management focuses on inducing a hypocoagulable state, improving blood flow, and providing supportive care. Ideally, all cats should be given 72 hours of treatment to determine the acute clinical course. Preventive protocols include antiplatelet and/or anticoagulant drugs, with the only prospective clinical trial demonstrating that clopidogrel is superior to aspirin with a lower CATE recurrence rate and longer time to recurrent CATE. Newer anticoagulant drugs hold great promise in the future of managing this disease.

KEYWORDS:

Cardiac; Cardioembolic; Cat; Feline; Stroke; Thrombosis

PMID:
28662872
DOI:
10.1016/j.cvsm.2017.05.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center